Published in Medical Devices and Surgical Technology Week, April 28th, 2002
The man had a diagnosis of dilated cardiomyopathy; he received the implanted device at Osaka University Hospital on March 23, 2001. Because of Japan's low incidence of organ transplantation, he may live with a device for the rest of his life.
World Heart Corp.'s Novacor LVAS is the only implantable ventricular assist device approved for commercial sale in Japan. It is estimated that more than 20,000 new cases of end-stage heart disease are diagnosed in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.